McKesson 2015 Annual Report Download - page 145

Download and view the complete annual report

Please find page 145 of the 2015 McKesson annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 146

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146

Directors and Officers Corporate Information
Board of Directors
John H. Hammergren
Chairman of the Board,
President and
Chief Executive Officer,
McKesson Corporation
Andy D. Bryant
Chairman of the Board,
Intel Corporation
Wayne A. Budd
Senior Counsel,
Goodwin Procter LLP
N. Anthony Coles, M. D.
Chairman and Chief Executive
Officer, Yumanity Therapeutics,
LLC; Formerly Chairman and
Chief Executive Officer, Onyx
Pharmaceuticals, Inc.
Alton F. Irby III
Chairman and
Founding Partner,
London Bay Capital
M. Christine Jacobs
Chairman of the Board,
President and Chief Executive
Officer, Retired, Theragenics
Corporation
Donald R. Knauss
Executive Chairman of the
Board, The Clorox Company
Marie L. Knowles
Executive Vice President and
Chief Financial Officer, Retired,
Atlantic Richfield Company
David M. Lawrence, M.D.
Chairman of the Board and
Chief Executive Officer, Retired,
Kaiser Foundation Health Plan,
Inc. and Kaiser Foundation
Hospitals
Edward A. Mueller
Chairman of the Board and
Chief Executive Officer, Retired,
Qwest Communications
International Inc.
Susan R. Salka
Chief Executive Officer and
President, AMN Healthcare
Services, Inc.
Corporate Officers
John H. Hammergren
Chairman of the Board,
President and
Chief Executive Officer,
McKesson Corporation
James A. Beer
Executive Vice President
and Chief Financial Officer
Patrick J. Blake
Executive Vice President
and Group President
Jorge L. Figueredo
Executive Vice President,
Human Resources
Paul C. Julian
Executive Vice President
and Group President
Bansi Nagji
Executive Vice President,
Corporate Strategy and
Business Development
Lori A. Schechter
Executive Vice President,
General Counsel and Chief
Compliance Officer
Brian P. Moore
Senior Vice President and
Treasurer
Nigel A. Rees
Senior Vice President and
Controller
Willie C. Bogan
Secretary
Common Stock
McKesson Corporation common stock is listed on the New York
Stock Exchange (ticker symbol MCK) and is quoted in the daily
stock tables carried by most newspapers.
Stockholder Information
Wells Fargo Shareowner Services, 1110 Centre Pointe Curve, Suite
101, Mendota Heights, MN 55120-4100 acts as transfer agent, regis-
trar, dividend-paying agent and dividend reinvestment plan agent
for McKesson Corporation stock and maintains all registered stock-
holder records for the Company. For information about McKes-
son Corporation stock or to request replacement of lost dividend
checks, stock certificates or 1099-DIVs, or to have your dividend
check deposited directly into your checking or savings account,
stockholders may call Wells Fargo Shareowner Services’ telephone
response center at (866) 614-9635. For the hearing impaired call
(651) 450-4144. Wells Fargo Shareowner Services also has a web-
site—www.wellsfargo.com/shareownerservices—that stockholders
may use 24 hours a day to request account information.
Dividends and Dividend Reinvestment Plan
Dividends are generally paid on the first business day of January, April,
July and October. McKesson Corporation’s Dividend Reinvestment
Plan offers stockholders the opportunity to reinvest dividends in
common stock and to purchase additional shares of common stock.
Stock in an individual’s Dividend Reinvestment Plan is held in book
entry at the Companys transfer agent, Wells Fargo Shareowner
Services. For more information, or to request an enrollment form, call
Wells Fargo Shareowner Services’ telephone response center at (866)
614-9635. From outside the United States, call +1-651-450-4064.
Annual Meeting
McKesson Corporation’s Annual Meeting of Stockholders will be
held at 8:30 a.m. PDT on Wednesday, July 29, 2015 at the Sofitel
San Francisco Bay, 223 Twin Dolphin Drive, Redwood City,
CA 94065.